Unknown NA INTERVENTIONAL NCT00749697

Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases

Investigating Absorbed Radiation Dose Delivered to Differentiated Thyroid Cancer Metastases Following Administration of Fixed Activity of Radioactive Iodine

Sponsor: Royal Marsden NHS Foundation Trust

Conditions Metastatic Sites Lung Bone Nodal Thyroid Carcinoma

Interventions SPECT scan

Updated 5 times since 2017 Last updated: Sep 8, 2008 Started: May 31, 2008 Primary completion: Jan 31, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Metastatic Sites Lung Bone Nodal and Thyroid Carcinoma and is currently ongoing. Royal Marsden NHS Foundation Trust leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Royal Marsden NHS Foundation Trust

Data source: Royal Marsden NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom